These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18618300)

  • 1. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
    Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
    BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHIT promotes the apoptosis of QBC939 by reducing the expression of cyclin D1.
    Huang Q; Xie F; Tang Z; Liu C; Wang C; Hu Y; Qiu L; Wang S; You H; Zhu K; Xu P
    Hepatogastroenterology; 2011; 58(107-108):713-8. PubMed ID: 21830375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
    Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
    J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma.
    Takada S; Morita K; Hayashi K; Matsushima T; Sawamura M; Murakami H; Nojima Y
    Eur J Haematol; 2005 Dec; 75(6):505-10. PubMed ID: 16313263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
    Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
    J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
    Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
    Yin C; Shen LJ; Xie SM; Ruan P; Yao X
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of fragile histidine triad expression in prostate carcinoma.
    Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
    Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.